Hundreds of lawsuits filed against some GLP-1 Makers over vision loss
Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
Australia news live: Liberal MP proposes using super to secure mortgages; BBC deletes crocodile post showing wrong river | Australia news
Bragg to float letting homebuyers use super as collateral for mortgages Andrew Bragg, the shadow minister for housing,…
Lawmaker opens up on GLP-1 journey and ‘strangest feeling’ after dropping 80 pounds – The Independent
Lawmaker opens up on GLP-1 journey and ‘strangest feeling’ after dropping 80 pounds The IndependentJB Pritzker Says He Used…
Andrographis dropped from listed medicines framework
ajp.com.au This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional…
What is ibogaine, and what does it treat?
Ibogaine, a psychoactive compound made from the roots of an African shrub, has been gaining popularity as a…
Video New lawsuits claim GLP-1 drugs led to vision loss – ABC News – Breaking News, Latest News and Videos
Video New lawsuits claim GLP-1 drugs led to vision loss ABC News – Breaking News, Latest News and VideosPatients…
Illinois Gov. JB Pritzker says he has lost 80 pounds on ‘life-changing’ GLP-1 medication
Illinois Gov. JB Pritkzer says he has lost 80 pounds while using a “life-changing” GLP-1 medication since he…
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations – Yahoo Finance
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations Yahoo FinanceNovo shares slide as drugmaker lays out post-Wegovy growth…
Stopping Ozempic may raise heart attack and stroke risk
GLP-1 drugs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have surged in popularity for…
Stopping Ozempic may raise heart attack and stroke risk
GLP-1 drugs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have surged in popularity for…
The Semaglutide Cliff vs. a 10x Multiple: Is Novo Nordisk (NVO) a Value Trap or a Bargain?
Morgan Stanley has cut Novo Nordisk A/S (NYSE:NVO) to Underweight on September 11, 2026. Semaglutide, the underlying molecule…
Karnataka cancels 16 licences, suspends 8 over spurious drugs: Full list
The Karnataka Food Safety and Drugs Administration (FSDA) has cancelled the licences of 16 pharmaceutical retailers and wholesalers,…